EWM
DGX icon

EPG Wealth Management’s Quest Diagnostics DGX Stock Holding History

EPG Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38
Closed -$3K – 279
2020
Q1 		$3K Hold
38
– – ﹤0.01% 651
2019
Q4 		$4K Buy
+38
New +$3.96K ﹤0.01% 537

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EPG Wealth Management's DGX Position: Q2 2020 in Review

EPG Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 38 shares — an estimated $3K sold.

EPG Wealth Management first reported a position in DGX in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 748 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • EPG Wealth Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • EPG Wealth Management sold 38 Quest Diagnostics shares in Q2 2020, an estimated $3K.
  • EPG Wealth Management first reported a position in Quest Diagnostics in Q4 2019 and held it in 2 quarters.
  • EPG Wealth Management's Quest Diagnostics position peaked at $4K in Q4 2019.
  • 748 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on EPG Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.